Bildkälla: Stockfoto

Moberg Pharma Q3’21: Important step taken during the quarter - Redeye

Redeyes continue to see steady progress during the quarter with the important step with the approval for the pediatric plan from EMA.

Redeyes continue to see steady progress during the quarter with the important step with the approval for the pediatric plan from EMA.
Börsvärldens nyhetsbrev
ANNONSER